Log in

Relevant bibliographies by topics / Seroprevalence; Varicella Zoster Virus / Journal articles

To see the other types of publications on this topic, follow the link: Seroprevalence; Varicella Zoster Virus.

Journal articles on the topic 'Seroprevalence; Varicella Zoster Virus'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Seroprevalence; Varicella Zoster Virus.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Ross, R. T., L. E. Nicolle, M. R. Dawood, Mary Cheang, and C. Feschuk. "Varicella Zoster Antibodies after Herpes Zoster, Varicella and Multiple Sclerosis." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 24, no. 2 (1997): 137–39. http://dx.doi.org/10.1017/s0317167100021478.

Full text

Abstract:

ABSTRACT:Background:We previously showed that Manitoba Hutterites seek physician care for varicella zoster virus infection significantly less than non-Hutterites. The current study was undertaken to measure varicella zoster virus seroprevalence for Hutterite and non-Hutterite controls.Methods:Blood was obtained from 315 Hutterites and 259 similar age and sex controls at the time of blood donations to The Canadian Red Cross Society. The controls were from the same or a contiguous postal code area and were collected at the same time as the Hutterite samples. The immune status of the specimens wa

APA, Harvard, Vancouver, ISO, and other styles

2

Srichomkwun, Panudda, Anucha Apisarnthanarak, Kanokporn Thongphubeth, Chananart Yuekyen, and Linda M. Mundy. "Evidence of Vaccine Protection Among Thai Medical Students and Implications for Occupational Health." Infection Control & Hospital Epidemiology 30, no. 6 (2009): 585–88. http://dx.doi.org/10.1086/597508.

Full text

Abstract:

In a cross-sectional study of Thai medical students, we compared the seroprevalence of antibody to measles virus, rubella virus, varicella zoster virus, hepatitis A virus, and hepatitis B virus with self-reports of prior infection or vaccination. Self-report predicted immunity to varicella zoster virus only. These data contribute to risk assessment and occupational health strategies in this resource-limited setting.

APA, Harvard, Vancouver, ISO, and other styles

3

Choi, Won Suk, Ji Yun Noh, Joong Yeon Huh, et al. "Seroprevalence of varicella-zoster virus in Korea." Journal of Medical Virology 82, no. 12 (2010): 2123–26. http://dx.doi.org/10.1002/jmv.21917.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Yusuf, H., and E.E. Ella. "SEROPREVALENCE OF VARICELLA-ZOSTER VIRUS INFECTION AMONG PRIMARY SCHOOL CHILDREN IN KADUNA STATE, NIGERIA." Continental J. Microbiology 5, no. 1 (2011): 1–5. https://doi.org/10.5281/zenodo.823835.

Full text

Abstract:

The study was carried out in the three geopolitical zone of Kaduna State, comprising Makarfi (Kaduna North) Kagarko (Kaduna South) and Igabi (Kaduna Central). A total of 353 serum samples collected, were tested VZV Immunoglobulin G (IgG) antibodies using a commercial IgG enzyme-linked immunosorbent assay (ELISA). The overall seroprevalence rate was 66.3%. Seroprevalence was 51.4% in the age group of 4-6 years, 64.7% in 7-9 years, 68.4 % in 10-12 years and 70.0 % in 13-15 years. The seroprevalence rate of VZV increased with age. There was significant relation between the presence of VZV antibod

APA, Harvard, Vancouver, ISO, and other styles

5

HAN, S. B., K. R. KANG, D. H. HUH, et al. "Seroepidemiology of varicella-zoster virus in Korean adolescents and adults using fluorescent antibody to membrane antigen test." Epidemiology and Infection 143, no. 8 (2014): 1643–50. http://dx.doi.org/10.1017/s0950268814002441.

Full text

Abstract:

SUMMARYWe conducted a cross-sectional seroepidemiological study in 2012–2013 to determine the seroprevalence of varicella-zoster virus (VZV) in adolescents and adults living in Korea, where varicella vaccination has been recommended universally at age 12–15 months since 2005. Residual serum samples were collected from 1196 healthy adults and adolescents aged ⩾10 years between November 2012 and March 2013. The fluorescent antibody to membrane antigen (FAMA) test and enzyme-linked immunosorbent assay (ELISA) were performed to determine the seroprevalence of VZV. The seroprevalences of VZV were c

APA, Harvard, Vancouver, ISO, and other styles

6

Yun, Ji Hyun, Eunsol Lee, Jeong Hwa Choi, Hyun Kyun Ki, and Jiho Park. "Seroprevalence of Varicella-Zoster Virus and Measles among Healthcare Workers in a Tertiary Medical Center in Korea." Vaccines 10, no. 11 (2022): 1956. http://dx.doi.org/10.3390/vaccines10111956.

Full text

Abstract:

Measles and varicella still occur in the general population despite the widespread vaccination against them, and healthcare workers (HCWs) are still at risk of exposure to these diseases. Here, we evaluated the seroprevalence of measles and varicella-zoster virus (VZV) in HCWs and the trend of seroprevalence according to age, birth year, and occupational group. The serostatuses of measles and VZV of HCWs during new employee medical examinations between October 2015 and October 2021 were included. Thereafter, the trends of seroprevalence according to age, birth year, and occupational groups wer

APA, Harvard, Vancouver, ISO, and other styles

7

Koskiniemi, Marjaleena, Maija Lappalainen, D. Scott Schmid, Elena Rubtcova, and Vladimir N. Loparev. "Genotypic Analysis of Varicella-Zoster Virus and Its Seroprevalence in Finland." Clinical and Vaccine Immunology 14, no. 9 (2007): 1057–61. http://dx.doi.org/10.1128/cvi.00348-06.

Full text

Abstract:

ABSTRACT We evaluated the seroprevalence of varicella-zoster virus (VZV) in the Finnish population among various age groups and genetically characterized VZV strains from documented cases of varicella and zoster. VZV-specific immunoglobulin G was measured in 2,842 serum samples that had been submitted for virological studies to the Department of Virology, University of Helsinki, from 1995 to 1996. Specimens for VZV genotyping were obtained from vesicular lesions from two pediatric patients and 26 adult patients. Seroprevalence to VZV varied markedly by age: 45% in children aged ≤2 months, 12.5

APA, Harvard, Vancouver, ISO, and other styles

8

Migasena, Sricharoen, Sriluck Simasathien, Varunee Desakorn, et al. "Seroprevalence of varicella-zoster virus antibody in Thailand." International Journal of Infectious Diseases 2, no. 1 (1997): 26–30. http://dx.doi.org/10.1016/s1201-9712(97)90007-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

MAHAMUD, A., J. LEUNG, Y. MASUNU-FALEAFAGA, et al. "Varicella zoster virus in American Samoa: seroprevalence and predictive value of varicella disease history in elementary and college students." Epidemiology and Infection 142, no. 5 (2013): 1002–7. http://dx.doi.org/10.1017/s095026881300174x.

Full text

Abstract:

SUMMARYThe epidemiology of varicella is believed to differ between temperate and tropical countries. We conducted a varicella seroprevalence study in elementary and college students in the US territory of American Samoa before introduction of a routine varicella vaccination programme. Sera from 515 elementary and 208 college students were tested for the presence of varicella-zoster virus (VZV) IgG antibodies. VZV seroprevalence increased with age from 76·0% in the 4–6 years group to 97·7% in those aged ⩾23 years. Reported history of varicella disease for elementary students was significantly a

APA, Harvard, Vancouver, ISO, and other styles

10

Dashraath, P., Eng-Seng Ong, and Vernon J. Lee. "Seroepidemiology of Varicella and the Reliability of a Self-reported History of Varicella Infection in Singapore Military Recruits." Annals of the Academy of Medicine, Singapore 36, no. 8 (2007): 636–41. http://dx.doi.org/10.47102/annals-acadmedsg.v36n8p636.

Full text

Abstract:

Introduction: Varicella is an acute disease with significant morbidity. However, there is little knowledge on the seroepidemiology of the disease in Singapore. The objective of this study was to assess the seroprevalence of varicella zoster virus (VZV) antibodies in military recruits in Singapore and to ascertain the predictive value of a self-reported history of varicella. The latter is a possible proxy for seroprevalence, and may be used to provide efficient identification of candidates for vaccination. Materials and Methods: From September 2000 to October 2005, 2189 servicemen were selected

APA, Harvard, Vancouver, ISO, and other styles

11

Wutzler, P., I. Färber, S. Wagenpfeil, H. Bisanz, and A. Tischer. "Seroprevalence of varicella-zoster virus in the German population." Vaccine 20, no. 1-2 (2001): 121–24. http://dx.doi.org/10.1016/s0264-410x(01)00276-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Dayan, G. H., M. S. Panero, R. Debbag, et al. "Varicella Seroprevalence and Molecular Epidemiology of Varicella-Zoster Virus in Argentina, 2002." Journal of Clinical Microbiology 42, no. 12 (2004): 5698–704. http://dx.doi.org/10.1128/jcm.42.12.5698-5704.2004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Munasingha, HathshyaM, Ananda Amarasinghe, NeelikaG Malavige, and Nalini Sathiakumar. "Seroprevalence of varicella zoster virus in Colombo district, Sri Lanka." Asian Pacific Journal of Tropical Medicine 11, no. 1 (2018): 53. http://dx.doi.org/10.4103/1995-7645.223561.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Dossary, Reem. "Seroprevalence of Varicella Zoster Virus in the Eastern Province of Saudi Arabia in Post-vaccination Era." Medical Archives 77, no. 5 (2023): 358. http://dx.doi.org/10.5455/medarh.2023.77.358-362.

Full text

Abstract:

Background: Varicella zoster virus (VZV) is a highly contagious virus causing two types of skin infections known as varicella and herpes zoster. Due to its high burden, vaccination is available in almost 42 counties worldwide including Saudi Arabia. Since its introduction, data on the impact of the vaccine from local and neighboring countries is lacking. Objective: This study was done to determine the seroprevalence of anti VZV IgG and IgM antibodies in post-vaccination era fifteen years after varicella vaccine introduction in routine childhood vaccination schedules. Methods: retrospective obs

APA, Harvard, Vancouver, ISO, and other styles

15

Maple, Peter A., Radu Tanasescu, Cris S. Constantinescu, et al. "Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy." Pathogens 13, no. 6 (2024): 499. http://dx.doi.org/10.3390/pathogens13060499.

Full text

Abstract:

Previous exposure to Epstein–Barr virus (EBV) is strongly associated with the development of multiple sclerosis (MS). By contrast, past cytomegalovirus (CMV) infection may have no association, or be negatively associated with MS. This study aimed to investigate the associations of herpesvirus infections with MS in an Italian population. Serum samples (n = 200) from Italian people with multiple sclerosis (PwMS) classified as the relapsing-and-remitting clinical phenotype and (n = 137) healthy controls (HCs) were obtained from the CRESM Biobank, Orbassano, Italy. Both PwMS and HCs samples were s

APA, Harvard, Vancouver, ISO, and other styles

16

MOSSONG, J., L. PUTZ, and F. SCHNEIDER. "Seroprevalence and force of infection of varicella-zoster virus in Luxembourg." Epidemiology and Infection 132, no. 6 (2004): 1121–27. http://dx.doi.org/10.1017/s0950268804002754.

Full text

Abstract:

A serological prevalence survey was carried out in Luxembourg during 2000–2001 to determine the antibody status of the Luxembourg population against vaccine-preventable infections including varicella-zoster virus (VZV). ELISA tests performed on 2679 sera indicated that 96 (3·6%) of the study population were seronegative. Age-specific seroprevalence rose rapidly from approximately 70% at age 4 years to 90% at age 6 years to 95% at age 12 years. Significant heterogeneity of seroprevalence was observed between the six different primary schools. For age groups 0–5, 6–11 and 12+ years, we estimated

APA, Harvard, Vancouver, ISO, and other styles

17

Çalışkan, Emel. "Evaluation of varicella zoster virus IgM, IgG and avidity results used in the diagnosis of varicella zoster virus." Anadolu Kliniği Tıp Bilimleri Dergisi 30, no. 2 (2025): 185–90. https://doi.org/10.21673/anadoluklin.1641218.

Full text

Abstract:

Aim: Varicella zoster virus (VZV) is a disease that is rapidly transmitted through the respiratory tract and has a high seroprevalence worldwide. This study aimed to evaluate the results of VZV IgM, VZV IgG and VZV avidity serological tests studied in our laboratory. Methods: In this study, the VZV IgM, VZV IgG, and VZV avidity test results in serum samples sent to our laboratory for preliminary diagnosis or screening of chickenpox between November 2019 and December 2024 were retrospectively examined. Kruskal-Wallis and Chi-Square tests were used to evaluate the results according to mean age,

APA, Harvard, Vancouver, ISO, and other styles

18

Fernando, Sirimali, GN Malavige, Ruvenika Mallikahewa, et al. "Seroprevalence of varicella zoster virus infections in Colombo District, Sri Lanka." Indian Journal of Medical Sciences 61, no. 3 (2007): 128. http://dx.doi.org/10.4103/0019-5359.30747.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Leung, Jessica, Adriana Lopez, Tarissa Mitchell, et al. "Seroprevalence of Varicella-Zoster Virus in Five US-Bound Refugee Populations." Journal of Immigrant and Minority Health 17, no. 1 (2013): 310–13. http://dx.doi.org/10.1007/s10903-013-9946-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Marziano, Valentina, Piero Poletti, Giorgio Guzzetta, Marco Ajelli, Piero Manfredi, and Stefano Merler. "The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study." Proceedings of the Royal Society B: Biological Sciences 282, no. 1804 (2015): 20142509. http://dx.doi.org/10.1098/rspb.2014.2509.

Full text

Abstract:

Varicella zoster virus (VZV) causes varicella upon first exposure and may reactivate later in life into herpes zoster (HZ), with a risk that is thought to be reduced by re-exposures to VZV. Given the decades-long time scales of reactivation and its dependence on the accumulation of re-exposure episodes, adopting a long-term perspective may be useful to correctly interpret current epidemiological trends of VZV. In this study, we investigate the possible impact of demographic changes on varicella and HZ in Spain, using an age-structured mathematical model informed with historical demographic dat

APA, Harvard, Vancouver, ISO, and other styles

21

Uduman, S. A., A. M. Tahira, R. Al Wash, M. A. Usmani, and A. Bener. "Varicella susceptibility among children and healthy adults in the United Arab Emirates." Eastern Mediterranean Health Journal 7, no. 4-5 (2001): 604–8. http://dx.doi.org/10.26719/2001.7.4-5.604.

Full text

Abstract:

The serological evidence of varicella zoster virus infection was determined among healthy individuals from infancy to 47 years of age living in this region. Of 648 people, 126 [19.4%] had no detectable antibody and were susceptible to infection. The overall adult seroprevalence rate was 81.3%. The rate among Emirati citizens increased with age; < 10 years, 45.8%; 11-20 years, 68.4%; 21-30 years, 89.5%; 31-40 years, 94.7%; and > 41 years, 88.9%. Adults from the Indian subcontinent and Philippines had variable prevalence rates and Sri Lankans living in the region were highly serosusceptibl

APA, Harvard, Vancouver, ISO, and other styles

22

Makhani, Naila, Brenda Banwell, Raymond Tellier, et al. "Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination." Multiple Sclerosis Journal 22, no. 3 (2015): 385–88. http://dx.doi.org/10.1177/1352458515595876.

Full text

Abstract:

Epstein–Barr virus (EBV) infection is associated with increased multiple sclerosis (MS) risk. Recently, cytomegalovirus (CMV) infection has been proposed as a protective factor against MS development. We determined EBV, herpes simplex virus, varicella-zoster virus and CMV seroprevalence in 247 prospectively followed children with acquired demyelinating syndromes (ADS). Remote EBV infection was more common in children with MS than those with monophasic ADS while CMV infection was more common in children with monophasic ADS. Children displaying evidence of remote EBV without CMV infection were a

APA, Harvard, Vancouver, ISO, and other styles

23

E. Briggs, Connie. "Varicella Vaccination as a Potential Multiple Sclerosis Prevention Strategy." International Journal on Bioinformatics & Biosciences 14, no. 3 (2024): 85–100. http://dx.doi.org/10.5121/ijbb.2024.14309.

Full text

Abstract:

Multiple sclerosis (MS), a chronic, debilitating central nervous system disease afflicting over 2.8 million people worldwide, is caused by unknown genetic and environmental factors, including delayed EpsteinBarr virus (EBV) infection. Here a hypothesis is proposed whereby MS is caused by primary EBV infection contracted after clade 3 varicella-zoster virus (VZV) infection. The hypothesis aligns with MS risk factors (latitude gradients, changing prevalence, sex ratios, migration factors, and viral antibody seroprevalence rates). The proposed hypothesis, which is rooted in the detection of VZV c

APA, Harvard, Vancouver, ISO, and other styles

24

Cao, Li-Juan, Yi-Ming Zheng, Fan Li, Hong-Jun Hao, and Feng Gao. "Varicella-zoster virus meningitis with hypoglycorrhachia: A case report." World Journal of Clinical Cases 11, no. 29 (2023): 7101–6. http://dx.doi.org/10.12998/wjcc.v11.i29.7101.

Full text

Abstract:

Time series analysis is a valuable tool in epidemiology that complements the classical epidemiological models in two different ways: Prediction and forecast. Prediction is related to explaining past and current data based on various internal and external influences that may or may not have a causative role. Forecasting is an exploration of the possible future values based on the predictive ability of the model and hypothesized future values of the external and/or internal influences. The time series analysis approach has the advantage of being easier to use (in the cases of more straightforwar

APA, Harvard, Vancouver, ISO, and other styles

25

Lafer, Manuel Mindlin, Maria Isabel de Moraes-Pinto, and Lily Yin Weckx. "Prevalence of IgG varicella zoster virus antibodies in the Kuikuro and Kaiabi indigenous communities in Xingu National Park, Brazil, before varicella vaccination." Revista do Instituto de Medicina Tropical de São Paulo 47, no. 3 (2005): 139–42. http://dx.doi.org/10.1590/s0036-46652005000300004.

Full text

Abstract:

The purpose of the study was to estimate the prevalence of IgG antibodies against varicella zoster virus (VZV) in the two most populated indigenous ethnic groups from Xingu Indigenous National Park, in Brazil, prior to the introduction of vaccination against the disease, and to determine the positive and the negative predictive values of a history of varicella infection. In 2001, 589 inhabitants of two Kuikuro villages and three Kaiabi villages were evaluated and provided information concerning previous varicella infection. An indirect immunosorbent assay (ELISA) to detect IgG anti-VZV antibod

APA, Harvard, Vancouver, ISO, and other styles

26

Samoilovich, E. О., A. M. Dronina, T. S. Guzovskaya, G. V. Semeiko, and M. A. Yermalovich. "Population Immunity to Varicella Zoster Virus in the Republic of Belarus." Epidemiology and Vaccinal Prevention 19, no. 6 (2021): 28–35. http://dx.doi.org/10.31631/2073-3046-2020-19-6-28-35.

Full text

Abstract:

Relevance. Chickenpox occupies a leading position in the structure of infectious pathology in the Republic of Belarus; 50,000-80,000 cases are registered annually in the country, including 2500-4500 cases among people over 15. Aims - to study the prevalence of IgG antibodies to Varicella Zoster virus among the population of the Republic of Belarus and assess the relative risk of infection for people of different ages. Materials and methods. The blood sera of 1190 people aged 2-75 from all 7 regions of the Republic of Belarus were investigated. IgG antibodies were detected using Serion ELISA cl

APA, Harvard, Vancouver, ISO, and other styles

27

Kang, Cheol-In, Chang-Min Choi, Tae-Sung Park, Dong-Jun Lee, Myoung-don Oh, and Kang-Won Choe. "Incidence of herpes zoster and seroprevalence of varicella-zoster virus in young adults of South Korea." International Journal of Infectious Diseases 12, no. 3 (2008): 245–47. http://dx.doi.org/10.1016/j.ijid.2007.08.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Riccò, Matteo, Pietro Ferraro, Salvatore Zaffina, et al. "Immunity to Varicella Zoster Virus in Healthcare Workers: A Systematic Review and Meta-Analysis (2024)." Vaccines 12, no. 9 (2024): 1021. http://dx.doi.org/10.3390/vaccines12091021.

Full text

Abstract:

Healthcare workers (HCWs) are occupationally exposed to varicella zoster virus (VZV), and their inappropriate vaccination status could contribute to an outbreak involving both professionals and the patients they care for, with a potential impact on the general population. Therefore, since 2007, the Advisory Committee on Immunization Practices (ACIP) recommends that all HCWs have evidence of immunity against varicella. The present meta-analysis was therefore designed to collect the available evidence on the seronegative status of VZV among HCWs. PubMed, Scopus, and Embase databases were searche

APA, Harvard, Vancouver, ISO, and other styles

29

SILHOL, R., F. P. ALVAREZ, C. ARENA, et al. "Micro and macro population effects in disease transmission: the case of varicella." Epidemiology and Infection 138, no. 4 (2009): 482–90. http://dx.doi.org/10.1017/s0950268809990896.

Full text

Abstract:

SUMMARYProfiles of varicella-zoster virus (VZV) seroprevalence have shown large variability in European countries in which vaccination has not been implemented. Differences in micro and macro population structures (e.g. household and municipality, respectively) may explain such variability, which is the focus of a population-based study of varicella in 12 000 children from 7800 French households in Corsica. The cumulative incidence was 89% at age 11 years, as the median age at infection was 5 years in first-born children, but decreased to 3·9 years in younger siblings. Hazard of infection in h

APA, Harvard, Vancouver, ISO, and other styles

30

Almuneef, Maha, Ziad A. Memish, Mostafa F. Abbas, and Hanan H. Balkhy. "Screening Healthcare Workers for Varicella-Zoster Virus: Can We Trust the History?" Infection Control & Hospital Epidemiology 25, no. 7 (2004): 595–98. http://dx.doi.org/10.1086/502445.

Full text

Abstract:

AbstractObjective:To determine the relationship between immunity and a history of chickenpox based on a self-administered questionnaire.Methods:We investigated immunity to varicella-zoster virus in a cohort of newly recruited employees with different job categories and different nationalities using enzyme-linked immunosorbent assay IgG.Results:There were 1,058 new recruits. Of these, 890 (84%) were immune and 168 (16%) were susceptible. The susceptibility rate was 23% (n = 77) for Asian, 15% (n = 14) for South African, 13% (n = 66) for Middle Eastern, and 9% (n = 11) for Western employees. Phy

APA, Harvard, Vancouver, ISO, and other styles

31

Fatha, Noorul, Li Wei Ang, and Kee Tai Goh. "Changing seroprevalence of varicella zoster virus infection in a tropical city state, Singapore." International Journal of Infectious Diseases 22 (May 2014): 73–77. http://dx.doi.org/10.1016/j.ijid.2013.10.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Vankova, O., T. Ulanova, and V. Loparev. "P1438 Seroprevalence and genotyping of Varicella zoster virus strains in the Russian Federation." International Journal of Antimicrobial Agents 29 (March 2007): S401—S402. http://dx.doi.org/10.1016/s0924-8579(07)71277-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Budihal, Ashwin, Madhuri Gudikote, Saranya Periyasamy, and Vidya R. "Clinical profile of herpes zoster in human immunodeficiency virus infected at a rural-based tertiary care center." National Journal of Physiology, Pharmacy and Pharmacology 14, no. 6 (2024): 1. http://dx.doi.org/10.5455/njppp.2024.14.05206202414052024.

Full text

Abstract:

Background: Due to the reactivation of the varicella-zoster virus, which had lainissed within sensory ganglions, herpes zoster (HZ) is typified by unilateral radicular pain and grouped vesicular eruption that is typically restricted to the dermatome innervated by a single spinal or cranial sensory ganglion. It is widely known that reactivation of varicella-zoster virus infection as HZ can cause morbidity in a human immunodeficiency virus (HIV)-positive host. Aims and Objectives: The aim of this study was to describe the clinical profile of HZ among HIV-positive patients in a rural tertiary car

APA, Harvard, Vancouver, ISO, and other styles

34

Lee, Seungjae, Hyo-Ju Son, Eunjung Lee, et al. "1433. Promoting Vaccination of Vaccine Preventable Diseases in Newly Employed Nurses and Doctors Guided by Serological Study." Open Forum Infectious Diseases 7, Supplement_1 (2020): S722. http://dx.doi.org/10.1093/ofid/ofaa439.1615.

Full text

Abstract:

Abstract Background Vaccination after serological evaluation of healthcare workers is key component of vaccine preventable diseases (VPDs) preparedness in hospital. The aim of this study is to determine the seroprevalence of VPDs and the vaccination rates among newly employed nurses and doctors. Methods A cross-sectional study was conducted at a referral university hospital in the Republic of Korea. All newly employed nurses and doctors without immunity were recommended to have the hepatitis B virus (HBV), varicella zoster virus (VZV), measles, mumps, and rubella (MMR), hepatitis A virus (HAV)

APA, Harvard, Vancouver, ISO, and other styles

35

GABUTTI, G., C. PENNA, M. ROSSI, et al. "The seroepidemiology of varicella in Italy." Epidemiology and Infection 126, no. 3 (2001): 433–40. http://dx.doi.org/10.1017/s0950268801005398.

Full text

Abstract:

We conducted a seroepidemiological study to evaluate the potential impact of mass varicella vaccination on the transmission of varicella-zoster virus (VZV) in Italy, where vaccination is not mandatory. We tested 3179 serum samples, collected from September 1996 to October 1997, for specific anti-VZV antibodies using a commercially available ELISA. The results confirmed that varicella typically involves children (82·1% seroprevalence among 10- to 14-year-olds) and that the mean age of acquiring the infection seems to be increasing. The results also revealed that southern Italy, compared to the

APA, Harvard, Vancouver, ISO, and other styles

36

KAFATOS, G., N. ANDREWS, K. J. McCONWAY, et al. "Estimating seroprevalence of vaccine-preventable infections: is it worth standardizing the serological outcomes to adjust for different assays and laboratories?" Epidemiology and Infection 143, no. 11 (2014): 2269–78. http://dx.doi.org/10.1017/s095026881400301x.

Full text

Abstract:

SUMMARYThe aim of the European Sero-Epidemiology Network 2 (ESEN2) project was to estimate age-specific seroprevalence for a number of vaccine-preventable diseases in Europe. To achieve this serosurveys were collected by 22 national laboratories. To adjust for a variety of laboratory methods and assays, all quantitative results were transformed to a reference laboratory's units and were then classified as positive or negative to obtain age-specific seroprevalence. The aim of this study was to assess the value of standardization by comparing the crude and standardized seroprevalence estimates.

APA, Harvard, Vancouver, ISO, and other styles

37

EFFELTERRE, T. VAN, Z. SHKEDY, M. AERTS, G. MOLENBERGHS, P. VAN DAMME, and P. BEUTELS. "Contact patterns and their implied basic reproductive numbers: an illustration for varicella-zoster virus." Epidemiology and Infection 137, no. 1 (2008): 48–57. http://dx.doi.org/10.1017/s0950268808000563.

Full text

Abstract:

SUMMARYThe WAIFW matrix (Who Acquires Infection From Whom) is a central parameter in modelling the spread of infectious diseases. The calculation of the basic reproductive number (R0) depends on the assumptions made about the transmission within and between age groups through the structure of the WAIFW matrix and different structures might lead to different estimates for R0 and hence different estimates for the minimal immunization coverage needed for the elimination of the infection in the population. In this paper, we estimate R0 for varicella in Belgium. The force of infection is estimated

APA, Harvard, Vancouver, ISO, and other styles

38

LERMAN, Y., G. CHODICK, S. TEPPER, G. LIVNI, and S. ASHKENAZI. "Seroepidemiology of varicella-zoster virus antibodies among health-care workers and day-care-centre workers." Epidemiology and Infection 132, no. 6 (2004): 1135–38. http://dx.doi.org/10.1017/s0950268804002791.

Full text

Abstract:

Inclusion of live varicella vaccine in the routine occupational health vaccination schedule requires knowledge of the natural immunity to varicella zoster virus (VZV) among high-risk occupations. This study aims were to evaluate VZV antibody positivity among health-care workers (HCWs) and day-care-centre workers (DCWs) and to assess its association with potential risk factors. Three groups of workers were tested for VZV antibody positivity: hospitals and community clinic HCWs (n=335), DCWs (n=117) and blue-collar workers as controls (n=121). The total VZV antibody positivity was 94·4%. There w

APA, Harvard, Vancouver, ISO, and other styles

39

Chaves, Tânia do Socorro Souza, Marta Heloisa Lopes, Vanda Akico Ueda Fick de Souza, et al. "Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients." Pediatric Transplantation 9, no. 2 (2005): 192–96. http://dx.doi.org/10.1111/j.1399-3046.2005.00279.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Wu, M. F., Y. W. Yang, W. Y. Lin, C. Y. Chang, M. S. Soon, and C. E. Liu. "Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection." Journal of Hospital Infection 80, no. 2 (2012): 162–67. http://dx.doi.org/10.1016/j.jhin.2011.11.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Zeynali, Ladan, Jamshid Ayatollahi, Mohammad Reza Sharifi, Mohammad Ali Tayebzadeh, Akram Sadat Ahmadi, and Masoud Doosti. "Seroprevalence of Antibodies against Varicella Zoster Virus among Women before Marriage in Yazd, Iran." Iranian Journal of Virology 10, no. 2 (2016): 1–6. http://dx.doi.org/10.21859/isv.10.2.3.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Salleras, Lluís, Àngela Domínguez, Pere Plans, et al. "Seroprevalence of varicella zoster virus infection in child and adult population of Catalonia (Spain)." Medical Microbiology and Immunology 197, no. 3 (2007): 329–33. http://dx.doi.org/10.1007/s00430-007-0064-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

VYSE, A. J., N. J. GAY, L. M. HESKETH, P. MORGAN-CAPNER, and E. MILLER. "Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults." Epidemiology and Infection 132, no. 6 (2004): 1129–34. http://dx.doi.org/10.1017/s0950268804003140.

Full text

Abstract:

This is the first large-scale study to investigate the seroprevalence of varicella zoster (VZV) in the general population of England and Wales. The study focused on those aged 1–20 years, that age group in whom most infections occur. Prevalence rose rapidly with age, with 53% of children showing evidence of prior infection by the age of 5 years and most young adults having experienced infection. In addition to using a fixed cut-off recommended by the manufacturer, a mixture modelling technique was also used to define the proportion of the population seropositive in each age group. This was sho

APA, Harvard, Vancouver, ISO, and other styles

44

MUÑOZ, M. P., A. DOMÍNGUEZ, and L. SALLERAS. "Estimated varicella incidence on the basis of a seroprevalence survey." Epidemiology and Infection 127, no. 3 (2001): 501–7. http://dx.doi.org/10.1017/s0950268801006264.

Full text

Abstract:

Varicella is a disease caused by varicella-zoster virus. It is transmitted via the respiratory route, is highly communicable and mainly affects young children. An effective vaccine is now available, whose routine use is advised by health authorities in the USA and which can prevent severe disease, although breakthrough infections do occur. In deciding whether or not to include a vaccine in the routine vaccination schedule, knowledge of the morbidity of the disease in question is fundamental. Although reporting of varicella is compulsory in Catalonia, doctors only have to report the weekly numb

APA, Harvard, Vancouver, ISO, and other styles

45

Chazan, Bibiana, Raul Colodner, Nava Teitler, Yael Chen, and Raul Raz. "Varicella zoster virus in health care workers in northern Israel: Seroprevalence and predictive value of history of varicella infection." American Journal of Infection Control 36, no. 6 (2008): 436–38. http://dx.doi.org/10.1016/j.ajic.2007.06.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Perez-Farinos, Napoleon, Luis Garcia-Comas, Rosa Ramirez-Fernandez, et al. "Seroprevalence of Antibodies to Varicella-zoster Virus in Madrid (Spain) in the Absence of Vaccination." Central European Journal of Public Health 16, no. 1 (2008): 41–44. http://dx.doi.org/10.21101/cejph.a3454.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

O'grady, Kerry-Ann, Angela Merianos, Mahomed Patel, and Lyn Gilbert. "High seroprevalence of antibodies to varicella zoster virus in adult women in a tropical climate." Tropical Medicine and International Health 5, no. 10 (2000): 732–36. http://dx.doi.org/10.1046/j.1365-3156.2000.00622.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Cardenas*, Andres, Ellen Smit, E. Andres Houseman, Nancy Kerkvliet, and Molly L. Kile. "Arsenic Exposure and Seroprevalence of the Varicella- Zoster Virus Igg Antibody in the US Population." ISEE Conference Abstracts 2014, no. 1 (2014): 1950. http://dx.doi.org/10.1289/isee.2014.o-140.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Doshi, Reena H., Vivian H. Alfonso, Patrick Mukadi, et al. "Low Varicella Zoster Virus Seroprevalence Among Young Children in the Democratic Republic of the Congo." Pediatric Infectious Disease Journal 37, no. 2 (2018): 138–43. http://dx.doi.org/10.1097/inf.0000000000001750.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Vandersmissen, G. "Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study." Occupational and Environmental Medicine 57, no. 9 (2000): 621–26. http://dx.doi.org/10.1136/oem.57.9.621.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!